Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 3
1958 1
1961 6
1962 8
1963 7
1964 2
1965 6
1966 5
1967 9
1968 6
1969 9
1970 9
1971 14
1972 12
1973 11
1974 8
1975 11
1976 13
1977 21
1978 12
1979 16
1980 11
1981 22
1982 30
1983 26
1984 20
1985 30
1986 38
1987 35
1988 45
1989 66
1990 44
1991 45
1992 43
1993 40
1994 40
1995 48
1996 43
1997 35
1998 46
1999 38
2000 52
2001 42
2002 50
2003 43
2004 44
2005 45
2006 43
2007 49
2008 62
2009 72
2010 60
2011 79
2012 89
2013 103
2014 88
2015 90
2016 90
2017 90
2018 85
2019 103
2020 130
2021 52
Text availability
Article attribute
Article type
Publication date

Search Results

2,349 results
Results by year
Filters applied: . Clear all
Page 1
The liver-brain-gut neural arc maintains the Treg cell niche in the gut.
Teratani T, Mikami Y, Nakamoto N, Suzuki T, Harada Y, Okabayashi K, Hagihara Y, Taniki N, Kohno K, Shibata S, Miyamoto K, Ishigame H, Chu PS, Sujino T, Suda W, Hattori M, Matsui M, Okada T, Okano H, Inoue M, Yada T, Kitagawa Y, Yoshimura A, Tanida M, Tsuda M, Iwasaki Y, Kanai T. Teratani T, et al. Among authors: harada y. Nature. 2020 Sep;585(7826):591-596. doi: 10.1038/s41586-020-2425-3. Epub 2020 Jun 11. Nature. 2020. PMID: 32526765
Combination molecular therapies for type 1 spinal muscular atrophy.
Harada Y, Rao VK, Arya K, Kuntz NL, DiDonato CJ, Napchan-Pomerantz G, Agarwal A, Stefans V, Katsuno M, Veerapandiyan A. Harada Y, et al. Muscle Nerve. 2020 Oct;62(4):550-554. doi: 10.1002/mus.27034. Epub 2020 Aug 10. Muscle Nerve. 2020. PMID: 32710634
Glycometabolic Regulation of the Biogenesis of Small Extracellular Vesicles.
Harada Y, Nakajima K, Suzuki T, Fukushige T, Kondo K, Seino J, Ohkawa Y, Suzuki T, Inoue H, Kanekura T, Dohmae N, Taniguchi N, Maruyama I. Harada Y, et al. Cell Rep. 2020 Oct 13;33(2):108261. doi: 10.1016/j.celrep.2020.108261. Cell Rep. 2020. PMID: 33053347 Free article.
The Reply.
Uehara K, Harada Y. Uehara K, et al. Among authors: harada y. Am J Med. 2020 May;133(5):e211. doi: 10.1016/j.amjmed.2019.12.048. Am J Med. 2020. PMID: 32450955 No abstract available.
The Reply.
Yokose M, Harada Y, Shimizu T. Yokose M, et al. Among authors: harada y. Am J Med. 2020 Jun;133(6):e328. doi: 10.1016/j.amjmed.2020.02.011. Epub 2020 Apr 14. Am J Med. 2020. PMID: 32299604 No abstract available.
Overexpression of RUNX3 Represses RUNX1 to Drive Transformation of Myelodysplastic Syndrome.
Yokomizo-Nakano T, Kubota S, Bai J, Hamashima A, Morii M, Sun Y, Katagiri S, Iimori M, Kanai A, Tanaka D, Oshima M, Harada Y, Ohyashiki K, Iwama A, Harada H, Osato M, Sashida G. Yokomizo-Nakano T, et al. Among authors: harada y. Cancer Res. 2020 Jun 15;80(12):2523-2536. doi: 10.1158/0008-5472.CAN-19-3167. Epub 2020 Apr 27. Cancer Res. 2020. PMID: 32341038
Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study.
Harada Y, Nagata Y, Kihara R, Ishikawa Y, Asou N, Ohtake S, Miyawaki S, Sakura T, Ozawa Y, Usui N, Kanamori H, Ito Y, Imai K, Suehiro Y, Kobayashi S, Kitamura K, Sakaida E, Onizuka M, Takeshita A, Ishida F, Suzushima H, Ishizawa K, Naoe T, Matsumura I, Miyazaki Y, Ogawa S, Kiyoi H; Japan Adult Leukemia Study Group JALSG. Harada Y, et al. Leuk Res. 2018 Mar;66:20-27. doi: 10.1016/j.leukres.2018.01.008. Epub 2018 Jan 17. Leuk Res. 2018. PMID: 29360622 Clinical Trial.
2,349 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page